Risk factors for ciprofloxacin-resistant Campylobacter infection in Wales

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 2, 2009, Pages 424-427

  Evans, Meirion R ^a,b   Northey, Gemma ^a   Sarvotham, Tinnu S ^a   Hopkins, A Lynne ^a   Rigby, Christine J ^a   Thomas, Daniel Rh ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b PUBLIC HEALTH WALES   (United Kingdom)

Author keywords

Case control studies; Drug resistance; Fluoroquinolones

Indexed keywords

CIPROFLOXACIN; DRINKING WATER; MINERAL WATER; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CAMPYLOBACTER; CAMPYLOBACTERIOSIS; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG UTILIZATION; FEMALE; FLUID INTAKE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; POULTRY; RISK FACTOR; TRAVEL; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; CASE-CONTROL STUDIES; CIPROFLOXACIN; DRINKING; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TRAVEL; WALES; YOUNG ADULT;

EID: 67650721250     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp179     Document Type: Article

References (10)

1. Allos BM. Campylobacter jejuni infections: Update on emerging issues and trends. Clin Infect Dis 2001; 32: 1201-6.
2. Engberg J, Aarestrup FM, Taylor DE et al. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: Resistance mechanisms and trends in human isolates. Emerg Infect Dis 2001; 7: 24-34.
3. Luangtongkum T, Jeon B, Han J et al. Antibiotic resistance in Campylobacter: Emergence, transmission and persistence. Future Microbiol 2009; 4: 189-200.
4. Phillips I, Casewell M, Cox T et al. Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother 2004; 53: 28-52.
5. King A. Recommendations for susceptibility test on fastidious organisms and those requiring special handling. J Antimicrob Chemother 2001; 48 Suppl 1: 77-80.
6. Smith KE, Besser JM, Hedberg CW et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999; 340: 1525-32.
7. Kassenborg HD, Smith KE, Vugia DJ et al. Fluoroquinolone-resistant Campylobacter infections: Eating poultry outside of the home and foreign travel are risk factors. Clin Infect Dis 2004; 38 Suppl 3: S279-84.
8. The Campylobacter Sentinel Surveillance Scheme Collaborators. Ciprofloxacin resistance in Campylobacter jejuni: Case-case analysis as a tool for elucidating risks at home and abroad. J Antimicrob Chemother 2002; 50: 561-8.
9. Tatchou-Nyamsi-König JA, Moreau A, Federighi M et al. Behaviour of Campylobacter jejuni in experimentally contaminated bottled natural mineral water. J Appl Microbiol 2007; 103: 280-8.
10. Cools I, Uyttendaele M, Caro C et al. Survival of Campylobacter jejuni strains of different origin in drinking water. J Appl Microbiol 2003; 94: 886-92.